HERON THERAPEUTICS INC's ticker is HRTX and the CUSIP is 427746102. A total of 190 filers reported holding HERON THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 0.41 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $60,868 | -50.6% | 59,095 | -44.3% | 0.01% | -23.1% |
Q2 2023 | $123,128 | -85.7% | 106,145 | -81.4% | 0.01% | -88.7% |
Q1 2023 | $863,275 | -39.6% | 571,705 | -0.0% | 0.12% | -41.6% |
Q4 2022 | $1,429,637 | -47.3% | 571,855 | -11.1% | 0.20% | -54.5% |
Q3 2022 | $2,714,000 | +51.8% | 643,115 | +0.4% | 0.43% | +71.8% |
Q2 2022 | $1,788,000 | -47.7% | 640,840 | +7.1% | 0.25% | -40.7% |
Q1 2022 | $3,422,000 | -34.3% | 598,265 | +4.9% | 0.42% | -39.6% |
Q4 2021 | $5,206,000 | +9.8% | 570,240 | +28.6% | 0.70% | +4.1% |
Q3 2021 | $4,740,000 | -60.7% | 443,385 | -42.9% | 0.68% | -59.7% |
Q2 2021 | $12,054,000 | +42.8% | 776,700 | +49.1% | 1.68% | +26.0% |
Q1 2021 | $8,442,000 | -14.5% | 520,805 | +11.7% | 1.33% | -22.3% |
Q4 2020 | $9,872,000 | +12.0% | 466,437 | -21.6% | 1.72% | -4.9% |
Q3 2020 | $8,817,000 | +0.8% | 594,913 | +0.0% | 1.80% | -6.6% |
Q2 2020 | $8,749,000 | +26.6% | 594,771 | +1.0% | 1.93% | +24.3% |
Q1 2020 | $6,912,000 | -40.0% | 588,732 | +20.2% | 1.55% | -17.8% |
Q4 2019 | $11,514,000 | – | 489,960 | – | 1.89% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
TANG KEVIN C | 760 | $783 | 100.00% |
Velan Capital Investment Management LP | 6,986,744 | $7,196,346 | 5.80% |
Tejara Capital Ltd | 2,109,681 | $2,172,971 | 1.23% |
JW Asset Management, LLC | 2,407,418 | $2,479,641 | 1.07% |
Rubric Capital Management LP | 26,713,503 | $27,514,908 | 1.03% |
GREAT POINT PARTNERS LLC | 4,737,368 | $4,879,489 | 0.89% |
Orchard Capital Management, LLC | 2,142,823 | $2,207,108 | 0.82% |
Clearline Capital LP | 6,149,842 | $6,334,338 | 0.54% |
CM Management, LLC | 450,000 | $463,500 | 0.49% |
JACOB ASSET MANAGEMENT OF NEW YORK LLC | 327,450 | $337,274 | 0.48% |